BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 29592967)

  • 1. Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study.
    Wan EYF; Yu EYT; Chin WY; Fung CSC; Fong DYT; Choi EPH; Chan AKC; Lam CLK
    Diabetes Care; 2018 Jun; 41(6):1134-1141. PubMed ID: 29592967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do We Need a Patient-Centered Target for Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes Mellitus?
    Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
    Hypertension; 2017 Dec; 70(6):1273-1282. PubMed ID: 29038204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world evidence of suboptimal blood pressure control in patients with type 2 diabetes.
    Walraven I; Mast MR; Hoekstra T; Jansen AP; Rauh SP; Rutters FR; van der Heijden AA; Elders PJ; Moll AC; Polak BC; Dekker JM; Nijpels G
    J Hypertens; 2015 Oct; 33(10):2091-8. PubMed ID: 26237560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Early Hypertension Control and Cardiovascular Disease Incidence in Veterans With Diabetes.
    Raghavan S; Ho YL; Kini V; Rhee MK; Vassy JL; Gagnon DR; Cho K; Wilson PWF; Phillips LS
    Diabetes Care; 2019 Oct; 42(10):1995-2003. PubMed ID: 31515207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
    Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Target Blood Pressure and Risk of Cardiovascular Disease in Low-Risk Younger Hypertensive Patients.
    Kwon CH; Kang J; Cho A; Chang Y; Ryu S; Sung KC
    Am J Hypertens; 2019 Aug; 32(9):833-841. PubMed ID: 31045225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lower achieved blood pressure on outcomes in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
    J Hypertens; 2012 Apr; 30(4):802-10; discussion 810. PubMed ID: 22343536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure: overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 Nov; 35(11):2138-2149. PubMed ID: 28858983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Visit-to-Visit Variability of Systolic Blood Pressure With Cardiovascular Disease and Mortality in Primary Care Chinese Patients With Type 2 Diabetes-A Retrospective Population-Based Cohort Study.
    Wan EY; Fung CS; Yu EY; Fong DY; Chen JY; Lam CL
    Diabetes Care; 2017 Feb; 40(2):270-279. PubMed ID: 27899498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of all-cause mortality to average on-treatment systolic blood pressure is significantly related to baseline systolic blood pressure: implications for interpretation of the Systolic Blood Pressure Intervention Trial study.
    Okin PM; Kjeldsen SE; Devereux RB
    J Hypertens; 2018 Apr; 36(4):916-923. PubMed ID: 29176391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure).
    Imai E; Ito S; Haneda M; Harada A; Kobayashi F; Yamasaki T; Makino H; Chan JC
    Nephrol Dial Transplant; 2016 Mar; 31(3):447-54. PubMed ID: 26152402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.
    Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Marx N; Sliwa K; Weber MA; Williams B; Yusuf S
    Eur Heart J; 2019 Jul; 40(25):2032-2043. PubMed ID: 30919899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
    Ilkun OL; Greene T; Cheung AK; Whelton PK; Wei G; Boucher RE; Ambrosius W; Chertow GM; Beddhu S
    Diabetes Care; 2020 Aug; 43(8):1878-1884. PubMed ID: 32366577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis.
    Bundy JD; Li C; Stuchlik P; Bu X; Kelly TN; Mills KT; He H; Chen J; Whelton PK; He J
    JAMA Cardiol; 2017 Jul; 2(7):775-781. PubMed ID: 28564682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-Specific Associations Between Systolic Blood Pressure and Cardiovascular Disease: A 10-Year Diabetes Mellitus Cohort Study.
    Wan EYF; Yu EYT; Chin WY; Wong ICK; Chan EWY; Chen S; Lam CLK
    J Am Heart Assoc; 2020 Jul; 9(14):e015771. PubMed ID: 32673523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
    Nichols GA; Joshua-Gotlib S; Parasuraman S
    J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure.
    Takao T; Kimura K; Suka M; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    J Diabetes Complications; 2015 Jul; 29(5):699-706. PubMed ID: 25861721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.